UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in URGN — UroGen Pharma Ltd.
CIK 861177
NEW YORK, NY
Position in URGN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$852,593
+$843,155 QoQ
Shares Held
47,419
+11666.5% QoQ
Ownership
0.097%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
15 quarters on record
Voting authority
Sole 46%
Shared 0%
None 54%
Common Shares in URGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,605,811 across 211 Biotechnology names. URGN ranks #130 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in URGN
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $852,593 | 47,419 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $9,438 | 403 | Shares | Defined | 2026-02-13 | |
| 2025-03-31 | $48,227,395 | 4,360,524 | Shares | Other | 2025-05-19 | |
| 2024-12-31 | $14,666,710 | 1,377,156 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $17,031,614 | 1,341,072 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $22,149,600 | 1,320,000 | Shares | Defined | 2024-08-14 | |
| 2022-03-31 | $195,104 | 22,400 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $213,024 | 22,400 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $376,768 | 22,400 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $342,048 | 22,400 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $436,352 | 22,400 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $403,648 | 22,400 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $432,096 | 22,400 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $498,918 | 19,101 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $388,929 | 21,801 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||